Latest Psychedelic Research


Researchers are studying a novel approach to smoking cessation that involves the use of a psychedelic in a safe and supportive setting


Psilocybin is being studies as a potential aid for depression in early Alzheimer’s disease. To find out more about this study..


Researchers at Johns Hopkins University are seeking individuals ages with anorexia nervosa to participate in a research study looking at the effects of psilocybin

Psilocybin for Co-occurring Depression and Alcohol Use Disorder
Researchers at the Johns Hopkins University are seeking individuals with depression who also drink alcohol regularly to participate in a research study looking at the effects of psilocybin

Psilocybin and Lyme Disease Study
Effects of Psilocybin in Post-Treatment Lyme Disease. Researchers at Johns Hopkins University are studying psilocybin – a psychoactive substance found in certain kinds of mushrooms


Study is looking at the effects of psilocybin, a naturally occurring compound contained in hundreds of species of psychoactive mushrooms, on electrical activity in the brain.

Psychedelic & Romantic Relationships Survey
Johns Hopkins Center for Psychedelic and Consciousness Research, researchers at Columbia University are seeking couples in which at least one person has used a psychedelic (e.g., mushrooms, LSD, ayahuasca) while in a romantic relationship.

Breathwork for Trauma & PTSD
Breathwork for Trauma & PTSD – Johns Hopkins Center is seeking individuals who have used breathwork to help with anxiety, depression, trauma, or PTSD symptoms to contribute.

Taking psychedelics can be like air travel: people do it all the time, it’s usually fine, but when it’s not fine, it’s sometimes very bad. We’ve been there. And that’s where an experienced GUIDE can make the difference in the outcome. I’m available by phone if you or someone you know wants to ask questions of ANY nature. Use this link to schedule a call HERE.

Researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression.